|
Etoricoxib Solution, 100ppm;Etoricoxib (MK-663;Etoricoxib Tablets;Etoricoxib(5-chloro-6'-Methyl-3-(4-(Methylsulfonyl)phenyl)-2,3'-bipyridine;
|
依托考昔；2,3'-聯(lián)吡啶, 5-氯-6'-甲基-3-[4-(甲基磺?；?苯基]-;依托考西;依他昔布
|
202409-33-4
|
|
AZD2281(olaparib);4-(3-(1-(cyclopropanecarbonyl)piperazine-4-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one
|
奧拉帕尼；PARP 抑制劑;4-[4-氟-3-(哌嗪-1-環(huán)丙基羰基)芐 基]-2H-酞嗪-1-酮;
|
763113-22-0
|
|
2,6-Dichlorophenolindophenol sodium salt xhydrate
|
2,6-二氯靛酚 鈉鹽 水合物
|
1266615-56-8
|
|
AZD-9291
|
邁瑞替尼
|
1421373-65-0
|
|
Nemorexant;Methanone, [(2S)-2-(6-chloro-7-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl][5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]-;Daridorexant
|
奈莫雷生;達利多雷生
|
1505484-82-1
|
|
CP-690550(Tasocitinib,CP690550);CP 690550(Tasocitinib);Tasocitinib;3-((3R,4R)-4-Methyl-3-(Me...;Tasocitinib (CP 690550)
|
托法替尼；3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯[2,3-D]嘧啶-4-基)胺基)哌啶-1-基)-3-氧代丙腈;
|
477600-75-2
|
|
Tetrabromophenol blue
|
四溴酚藍
|
4430-25-5
|
|
Morpholine hydrochloride
|
嗎啡啉鹽酸鹽
|
10024-89-2
|
|
E7080;LENVATINIB;E7080 (Lenvatinib);Lenvatinib (E7080);
|
樂伐替尼；樂伐替尼 4-[3-氯-4-(環(huán)丙基氨基羰基)氨基苯氧基]-7-甲氧基-6-喹啉甲酰胺;倫瓦替尼;樂伐替尼游離堿;樂伐替尼 LENVATINIB;侖伐替尼
|
417716-92-8
|
|
TG101348; TG 101348; TG-101348; SAR302503; SAR-302503; SAR 302503; FEDRATINIB.;TG101348(Fedratinib);CS-57;TG-101348; TG 101348;
|
fedratinib；JAK2抑制劑(TG-101348);費曲替尼;菲卓替尼;化合物FEDRATINIB;
|
936091-26-8
|
|
ApreMilast,CC-10004;brand name: Otezla.;CC10004; CC-10004; CC 10004; APREMILAST; BRAND NAME: OTEZLA.;
|
阿普斯特；匹米斯特;(+)-2-[1-(3-乙氧基-4-甲氧基苯基)-2-甲基磺酰乙基]-4-乙酰氨基異吲哚啉-Chemicalbook1,3-二酮;阿普斯特(APREMILAST);阿普司特;APREMILASTCC-10004阿普斯特
|
608141-41-9
|
|
KPT-330;(2Z)-3-[3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-2-propenoic acid 2-(2-pyrazinyl)hydrazide;Selinexor;
|
Selinexor；塞利尼索;塞靈克斯;(Z)-3-(3-(3,5-雙(三氟甲基)苯基)-1H-1,2,4-三唑-1-基)-N'-(吡嗪-2-基)丙烯酰肼
|
1393477-72-9
|
|
aprocitentan
|
阿西替坦
|
1103522-45-7
|
|
sparsentan
|
司帕生坦
|
254740-64-2
|
|
DFSX-2;Ethyl1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate;
|
德拉沙星;1-(6-氨基-3,5-二氟吡啶-2-基)-6-氟-7-[3-(異丁酰氧基)氮雜環(huán)丁烷-1-基]-4-氧代-1,4-二氫喹啉-3-甲酸乙酯;
|
442526-91-2
|
|
Linezolid-13C-d3;Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]- (9CI);
|
利奈唑胺；雷奈佐利(利奈唑胺);利奈唑胺(游離);嗎啉惡酮(標準品);雷奈佐利;利奈唑胺
|
165800-03-3
|
|
POLY(VINYL METHYL ETHER)
|
聚乙烯甲基醚、聚乙烯基甲醚
|
9003-09-3
|
|
Triisopropanolamine Borate
|
三異丙醇胺環(huán)硼酸鹽
|
101-00-8
|
|
Undecylenoyl phenylalanine
|
十一碳烯?；奖彼?/a>
|
175357-18-3
|
|
AZILSARTAN;2-Ethoxy-1-[[2'-(4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid Azilsartan;
|
阿齊沙坦；阿齊沙坦酯雜質(zhì)A;阿齊沙坦(降壓藥);阿齊沙坦INT E;阿奇沙坦 10G;阿齊沙坦, ≥98% (HPLC);阿齊沙坦原料藥;阿齊沙坦(阿齊主鏈)
|
147403-03-0
|
|
N(4)-hydroxycytidine
|
N-羥基胞苷
|
3258-02-4
|
|
2,5,6-TRICHLORO-1H-BENZIMIDAZOLE
|
2,5,6-三氯苯并咪唑
|
16865-11-5
|
|
Mirabegron;N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)-2-(2-aminothiazol-4-yl)acetamide;YM 178;Mirabegron(YM 178)
|
米拉貝??；米拉貝隆雜質(zhì)B;2-氨基-N-[4-[2-[[(2R)-2-羥基-2-苯基乙基]氨基]乙基]苯基]-4-噻唑乙酰胺;米拉貝隆API;
|
223673-61-8
|
|
Momelotinib
|
莫洛替尼
|
1056634-68-4
|
|
6-CHLORO-3-(1-METHYLETHYL)-2,4-(1H,3H)-PYRIMIDINEDIONE
|
6-氯-3-異丙基嘧啶-2,4(1H,3H)-二酮
|
887581-47-7
|
|
Vonoprazan;1-[5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrol-3-yl]-N-methylmethanamine;
|
沃諾拉贊；富馬酸沃諾他贊;沃諾拉贊間氟異構(gòu)體;凡諾帕胺;沃諾拉贊;
|
881681-00-1
|
|
2,4-Dichlorobenzenediazonium tetrafluoroborate
|
2,4二氯苯基重氮四氟硼酸鹽
|
21872-70-8
|
|
N-(2-Acetamido)iminodiacetic acid
|
乙酰氨基亞胺乙酸
|
26239-55-4
|
|
NS-304;Selexipag;ACT-293987;NS-304(Selexipag);Selexipag API
|
賽樂西帕；司來帕格;塞萊西帕格雜質(zhì);2-(4-((5,6-二苯基吡嗪-2-基)(異丙基)氨基)丁氧基)乙酸酯
|
475086-01-2
|
|
Regorafenib;BAY 73-4506;4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;
|
瑞戈非尼；瑞格菲尼無水物;瑞格菲尼及中間體;BAY 73-4506/ 瑞格非尼/ 4-[4-({[4-氯-3-(三氟甲基)苯基]氨基甲酰}氨基)-3-氟苯氧基]-N-甲基吡啶-2-甲酰胺;瑞格菲尼雜質(zhì);
|
755037-03-7
|
|
VX-770
|
依伐卡托
|
873054-44-5
|
|
Trametinib free base;Mekinist trametinib;Trametinib (GSK1120212,JTP 74057);Trametinib, >=98%;CS-30;Trametinib Impurity;100836
|
曲美替尼；曲美替尼游離堿;曲美替尼、GSK1120212;曲美替尼1;MEK抑制劑(TRAMETINIB)
|
871700-17-3
|
|
Irbinitinib;Irbinitinib(ARRY380);Irbinitinib (ARRY-380,Tucatinib,ONT 380);IRBINITINIB (ARRY-380; ONT-380)
|
妥卡替尼；6-[5-[[[2-(甲磺?；?乙基]氨基];HER2抑制劑(IRBINITINIB);中文名:妥卡替尼英文名:IRBINITINIB (ARRY-380);
|
937263-43-9
|
|
LEE011, >=98%;7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE;LEE-011, Ribociclib;
|
瑞博西利；LEE011 瑞柏司可里布 50MG;瑞柏司可里布;LEE011 瑞柏司可里布;7-環(huán)戊基-N,N-二甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]-7H-吡咯并[2,3-D]嘧啶-6-甲酰胺;
|
1211441-98-3
|
|
n-methyl-3-(2-methylphenoxy)benzenepropanamine;(r)-tomoxetine;Tomoxetine;TomoxetineHcl;
|
托莫西??；(R)-托莫西汀;(R)-N-甲基-3-(2-甲基苯氧)-3-苯丙胺;托莫西汀;托莫西汀雜質(zhì)F;托莫西汀雜質(zhì)G;托莫西汀雜質(zhì)B EP標準品
|
83015-26-3
|
|
Pirtobrutinib
|
LOXO-305
|
2101700-15-4
|
|
PF07321332(Paxlovid);nirmatrelvir;Nirmatrelvir (PF-07321332);PF-07321332-005;
|
帕羅韋德；PAXLOVID;帕克洛維德;帕羅韋德試劑;PF-07321333;
|
2628280-40-8
|
|
N-Desmethyl lmatinib
|
N-去甲基伊馬替尼
|
404844-02-6
|
|
PA-824
|
(S)-6,7-二氫-2-硝基-6-[[4-(三氟甲氧基)苯基]甲氧基]-5H-咪唑并[2,1-B][1,3]惡嗪
|
187235-37-6
|
|
Masitinib
|
馬賽替尼
|
790299-79-5
|
|
TAK-385;Relugolix;Altropane;TKA-385 Relugolix;
|
瑞盧戈利；1-(4-(1-(2,6-二氟芐基)-5-((二甲基氨基)甲基)-3-(6-甲氧基噠嗪-3-基)-2,4-二氧-1,2,3,4-四氫噻吩并[2,3-D]嘧啶-6-基)苯基)-3-甲氧基脲,
|
737789-87-6
|
|
Resmetirom (MGL-3196,VIA-3196);MGL-3196; MGL 3196; MGL3196; VIA-3196; VIA3196; VIA-3196;VIA3196;VIA-3196;
|
Resmetirom；RESMETIROM(MGL-3196);MGL-3196游離態(tài);化合物MGL3196;
|
920509-32-6
|
|
Resmetirom (MGL-3196,VIA-3196);MGL-3196; MGL 3196; MGL3196; VIA-3196; VIA3196; VIA-3196;VIA3196;VIA-3196;
|
Resmetirom；RESMETIROM(MGL-3196);MGL-3196游離態(tài);化合物MGL3196;
|
920509-32-6
|
|
0DM021;BAY-1841788;ODM-021;0DM021;ODM 021;ODM 021;ODM-021;ODM-201
|
達洛魯胺；達羅魯塔米德;達洛魯胺,達羅他胺;多拉米胺;N-((S)-1-(3-(3-氯-4-氰基苯基)-1H-吡唑-1-基)丙-2-基)-5-(1-羥乙基)-1H-吡唑-3-甲酰胺
|
1297538-32-9
|
|
2-Methoxy-4-morpholinobenzenediazonium chloride zinc chloride double salt
|
2-甲氧基-4-嗎啉基重氮苯氯化鋅鹽
|
67801-08-5
|
|
4'-AMINOPROPIOPHENONE
|
4-胺基丙苯酮
|
70-69-9
|
|
SPRYCEL;BMS354825;DASATINIB (BMS 354825);CS-1968;
|
達沙替尼；5-噻唑甲酰胺,N-(2-氯-6-甲基苯基)-2-[[6-[4-(2-羥基乙基)-1-哌嗪基]-2-甲基-4-嘧啶基]Chemicalbook氨基]-;DASA錫IB;達沙替尼無水物(N-6晶型)大粒徑(D50=30-60);達沙替尼無水物(N-6晶型)粉末狀;
|
302962-49-8
|
|
Ticagrelor, >=98%;Ticagrelo;Ticargrelor;Brilinta;Possia;Ticagrelor and intermediates;Ticagrelor Standards
|
替卡格雷；替格瑞洛;替卡格雷,替格雷洛,替格瑞洛;替卡格雷及中間體;替卡格雷標準品;替格瑞洛/替卡格雷;替格瑞洛;提卡格雷
|
274693-27-5
|
|
afamidis (Fx1006A);Tafamidis free acid;PF-06291826(Tafamidis);TafaMidis;Fx 1006;
|
Tafamidis ；他發(fā)米帝司甲葡胺;他發(fā)米帝司;氯苯唑酸;2-(3,5-二氯苯基)-6-苯并惡唑甲酸;他法米迪
|
594839-88-0
|
|
Empagliflozin(W.S);Empaglifloin;Empagliflozin API;BI-10773;BI 10773;BI10773;CS-798;EMPAGLIFLBZIN;EMpagliflozin;BI-10773
|
依帕列凈；艾格列凈;(1S)-1,5-脫水-1-(4-氯-3-{4-[(3S)-四氫呋喃-3-基氧基]芐基}苯基)-D-葡萄糖醇;
|
864070-44-0
|
|
Trelagliptin(syr472);Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-flChemicalbookuoro-;Trelagliptin(R)-2-[[6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]methyl]-4-fluorobenzonitrile;
|
曲格列?。磺窳型?;曲格列汀-INT E;曲格列汀;(R)-2-((6-(1-(3-胺哌啶基)-3-甲基-2,4-二氧雜-3,4-二氫吡啶基-1-(2H)-基)甲基)-4-氟苯甲氰
|
865759-25-7
|
|
Brexpiprazole
|
依匹哌唑
|
913611-97-9
|
|
Brexpiprazole
|
依匹哌唑
|
913611-97-9
|
|
LOXO-101;CS-2322;LOXO101;LOXO 101;LOXO-101,LAROTRECTINIB,ARRY-470 (LAROTRECTINIB SULFATE CAS:1223405-08-0);
|
拉羅替尼；拉洛替尼;拉羅托西尼雜質(zhì);拉羅特里尼雜質(zhì);原肌球蛋白受體激酶抑制劑(TRK抑制劑)(LOXO-101);
|
1223403-58-4
|
|
Tri(4-morpholinyl)phosphine oxide
|
三(4-嗎啉基)氧化膦
|
4441-12-7
|
|
Carbamic acid, (4,6-diamino-2-(1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-B)pyridin-3-yl)-5-pyrimidinyl)methyl-, methyl ester;Riociguat (BAY 63-2521);Riocguat;CS-718;Riociguat, BZY 632521
|
利奧西胍；磺達肝癸鈉中間體I(A-8);利奧西呱,BAY 63-2521;利奧西呱雜質(zhì)(A-D);利奧西呱雜質(zhì)D;利奧西呱(API);氘代鹽酸利莫那班;利奧西呱
|
625115-55-1
|
|
AF-802;CH-5424802/RG-7853;Alectinib (CH5424802);AF 802; AF-802; AF802; CH5424802; CH5424802; CH 5424802; RO5424802; RO 5424802; RO5424802, ALECTINIB;
|
艾樂替尼
|
1256580-46-7
|
|
AHU-377,149709-62-6;AHU-37;AHU377; AHU 377; SACUBITRIL
|
沙庫巴曲；CZ696原研900-04;塞克比曲纈沙坦復(fù)合物;AHU-377(鈉鹽);
|
149709-62-6
|
|
Salcaprozate Sodium
|
8-（2-羥基苯甲酰胺基）辛酸鈉
|
203787-91-1
|
|
BENZIMIDAVIR
|
馬立巴韋；BENZIMIDAVIR 苯并咪唑核苷;苯并咪唑核苷;
|
176161-24-3
|
|
1-(4-Nitrophenyl)acetone;2-Propanone,1-(4-nitrophenyl)-;
|
4-硝基苯丙酮；4-硝基苯丙酮,
|
5332-96-7
|
|
Methyl Green
|
甲基綠
|
7114-03-6
|
|
Cinacalcet Hydrochloride;N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride;
|
鹽酸甲狀旁腺激素；RAC西那卡塞-D3(甲基-D3)安泰樂;鹽酸西那卡塞(鹽酸甲狀旁腺激素);西那卡賽鹽酸鹽;
|
364782-34-3
|
|
ISOPROPYLUREA
|
異丙基脲
|
691-60-1
|
|
1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-,(+)-(9CI);IMegliMin;EMD 387008;R-IMegliMin;EMD 387008/R-Imeglimin;EMD 387008 (R-IMEGLIMIN) HCL;
|
伊美格列明；IMEGLIMIN游離態(tài);(+)-(9CI)-1,6-二氫-N,N,6-三甲基-1,3,5-三嗪-2,4-二胺;伊美格列明;依格列明;(2S)Chemicalbook-N6,N6,2-三甲基-1,2-二氫-1,3,5-三嗪-4,6-二胺;IMEGLIMIN(依美格列);依格列明/伊美格列明;化合物T22860
|
775351-65-0
|
|
linagliptin;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;
|
利拉利??；LINAGLIPTIN利拉利汀(BI-1356);利格利汀;歐唐寧;利拉利汀 1KG;利拉利汀API;利納利汀;利拉利汀原料藥;利格列汀
|
668270-12-0
|
|
Menaquinone 7
|
維生素K2（35）
|
2124-57-4
|
|
INTEDANIB BASE;Nintedanib;Nintedanib (BIBF 1120);Nintedanib/Intedanib/Vargatef;BIBF 1120; VARGATEF; INTEDANIB;INTEDANIB BASE;Intedanib Vargatef;Nintedanib-016;100837
|
尼達尼布；(3Z)-2,3-二氫-3-[[[4-[甲基[2-(4-甲基-1-哌嗪基)乙酰]氨基]苯基]氨基]苯亞甲基]-2-氧代-1H-吲哚-6-甲酸甲酯;尼達尼布乙烷磺酸鹽;尼達尼布雜質(zhì)(A-D)
|
656247-17-5
|
|
5',5''-Dinitro-3',3''-diiodo-3,4,5,6-trtrabromophenol-sulfonephthalein
|
5', 5''-二硝基-3', 3''-二碘基-3,4,5,6-四溴酚磺酞
|
145551-16-2
|
|
Carbozantinib;Cabozantinib(XL184Malate);Cabozantinib (XL184, BMS-907351);
|
卡博替尼；XL184(博卡替尼);XL-184(卡博替尼);卡博替尼堿;卡博替尼 100MG;
|
849217-68-1
|
|
Abemaciclib, >=98%;Abemaciclib;abemaciclib(CDK 4/6 inhibitor);Abemaciclib (LY2835219);Bemaciclib(LY2835219, abemaciclib);CDK4/6 dual inhibitor;
|
阿貝西利；阿貝昔利布;玻瑪西尼;阿貝西尼;N-(5-((4-乙基哌嗪-1-基)甲基)吡啶-2-基)-5-氟-4-(4-氟-1-異丙基-2-甲基-1H-苯并[D]咪唑-6-基)嘧啶-2-胺;
|
1231929-97-7
|
|
LasMiditan;2,4,6-trifluoro-N-(6-(1-Methylpiperidine-4-carbonyl)pyridin-2-yl)benzaMide;COL-144; LY573144;CS-2381;COL-144; LY-573144;COL144; LY 573144;
|
拉米地坦；拉米迪坦;2,4,6-三氟-CHEMICALBOOKN-[6-[(1-甲基-4-哌啶基)羰基]-2-吡啶基]苯甲酰胺;拉米地坦/拉斯米地坦
|
439239-90-4
|
|
7-Chloro-[1,2,4]triazolo[1,5-a]pyridine
|
7-氯-[1,2,4]三唑并[1,5-A]吡啶
|
1427452-48-9
|
|
Finerenone (BAY 94-8862);(4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide;BAY 94-8862;BAY948862;
|
非奈利酮；化合物FINERENONE;(4S)-4-(4-氰基-2-甲氧基苯基)-5-乙氧基-1,4-二氫-2,8-二甲基-1,6-萘啶-3-甲酰胺;FINERENONE 非萘立酮 BAY 94-8862
|
1050477-31-0
|
|
ETC-1002;Bempedoic Acid;ETC-1002 (ESP 55016);ESP 55016;ETC-1002(BEMPEDOIC ACID);CS-1544;Bempedoic Acid(ETC-1002;Bempedoate
|
貝派地酸；8-羥基-2,2,14,14-四甲基十五烷二酸;貝派度酸API;8-羥基-2,2,14,14-四甲基Chemicalbook十五烷二酸(貝派度酸);苯丙醚酸;ETC-1002游離態(tài);貝派地酸API;ETC-1002(貝派地酸)
|
738606-46-7
|
|
Trilaciclib
|
曲拉西利；G1T28 ; G1T-28 ; G1T 28 ; TRILACICLIB.;曲拉西利;骨髓保護劑;化合物 T13202L
|
1374743-00-6
|
|
Trilaciclib
|
曲拉西利
|
1374743-00-6
|
|
ROFLUMILAST;3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide;B 9302-107;BY 217;BYK 20869;Daxas;
|
羅氟司特；/ROFLUMILAST/3-(環(huán)丙甲氧基)-N-(3,5-二氯-4-吡啶基)-4-(二氟甲氧基)苯甲酰胺;達菲寧Chemicalbook;3-(環(huán)丙基甲氧基)-N-(3,5-二氯-4-吡啶基)-4-(二氟甲氧基)苯甲酰胺;
|
162401-32-3
|
|
Trilaciclib
|
|
|
|
TAK-788
|
莫博替尼
|
1847461-43-1
|
|
TAK-788
|
莫博替尼
|
1847461-43-1
|
|
ensifentrine
|
恩塞芬汀
|
1884461-72-6
|
|
1,2,3,4-tetrahydro-benzo[h]quinolin-3-ol hydrochloride
|
1,2,3,4-四氫苯并喹啉-3-酚鹽酸鹽
|
73579-26-7
|
|
ACT 064992;ACT-064992;ACT-064992 / ACT064992;Macitentan, >=99%;
|
馬西替坦；艾德拉尼中間體1;馬西;馬昔替坦;馬西替坦 API;麥西騰坦
|
441798-33-0
|
|
4-Aminopiperidine-4-carboxylic acid
|
4-氨基哌啶-4-羧酸
|
40951-39-1
|
|
Aripiprazole
|
阿立哌唑
|
129722-12-9
|
|
Aripiprazole
|
阿立哌唑
|
129722-12-9
|
|
AV951 (KRN951, Tivozanib) (stopped use since the patent issue);AV-951; KRN951; AV 951;AV951;CS-8;
|
替沃扎尼；N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-異惡唑基)脲;
|
475108-18-0
|
|
vericiguat
|
維利西呱
|
1350653-20-1
|
|
Ethyl Isocyanatoacetate
|
異氰酰乙酸乙酯
|
2949-22-6
|
|
Exatecan;DX 8951;CS-147;Exatecan Impurity;
|
依喜替康；依喜替康雜質(zhì);伊立替康雜質(zhì)36;伊喜替康
|
171335-80-1
|
|
ALOGLIPTIN(ALOG
LIPTINE, ALOGLIPTINA)
|
阿格列?。话⒙謇?曲格列汀雜質(zhì)T;2-[[6-[(3R)-3-氨基-1-哌啶基]-3,4-二氫-3-甲基-2,4-二氧Chemicalbook代-1(2H)-嘧啶基]甲基]苯甲腈(阿格列汀,又名:阿洛利停);苯甲酸阿格列汀原料藥;苯甲酸阿格列汀中間體2
|
850649-61-5
|
|
DAPAGLIFLOZIN;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol;Dapagliflozin propanediol;BMS-512148-05;Dapagliflozin S1548 Selleck;DAPAGLIFLOZIN BASE;Daglican;Dapagliflozi
|
達格列凈；達格列嗪 50G;達格列凈 (游離堿);達格列凈 / (1S)-1,5-脫水-1-C-[4-氯-3-[(4-乙氧基苯基)甲基]苯基]-D-葡萄糖醇;達格列凈(無水);達帕格列佛嗪雜質(zhì)
|
461432-26-8
|
|
Sorafenib free base for research;Sorafenib Free Base;Forafenib;Sorafenib free base(Bay43-9006);nexavar,sorafenib;BAY43-9006; NEXAVAR;Nexavar;Sorafenib-d4
|
索拉非尼；索拉非尼及中間體;所拉菲尼;SORAFENIB TOSYLATE 索拉非尼;RAF抑制劑;4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺;甲苯磺酸索拉替尼(替尼類);索拉替尼
|
284461-73-0
|
|
ABT 492 MegluMine;ABT492 MegluMine;ABT-492 MegluMine;Delafloxacin (MegluMine)
|
德拉沙星葡甲胺鹽；德拉沙星N-甲基葡萄糖胺鹽;德拉沙星葡甲胺鹽;地拉沙星葡甲胺;德拉沙星葡甲胺;
|
352458-37-8
|
|
Lifitegrast-d4;Lifitegrast Impurity;lifitegrast;Lifitegrast, SAR 1118
|
立他司特；利菲司特;立他斯特雜質(zhì);
|
1025967-78-5
|
|
entrecitinib;Entrectinib(RXDX-101)
|
恩曲替尼；恩曲替尼;TRK/ROS1/ALK抑制劑;恩曲替尼RXDX-101;RXDX-101恩曲替尼;NVP-LGK974, WNT974
|
1108743-60-7
|
|
Solriamfetol;(S)-2-amino-3-phenylpropyl carbamate hydrochloride
|
solriamfetol；索利氨酯
|
561069-23-6
|
|
reproxalap
|
REPROXALAP
|
916056-79-6
|
|
3-(N-tosyl-L-alanyloxy)-indole
|
3-（N-對甲苯磺?；?L-丙氨酰氧基）-吲哚
|
75062-54-3
|